Scotland · NHS Scotland MSAN
Bumetanide 1mg and 5mg tablets
MSAN(2023)33 · Level 3 · issued 16 Oct 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Bumetanide 5mg tablets are out of stock until early March 2024. | Out of stock | early March 2024 |
| 2. Bumetanide 1mg tablets remain available until the end of October and will be out of stock until | Out of stock | the end of October and will be out of stock until |
| 3. Bumetanide 1mg/5ml SF oral solution remains available but is unable to support increased | Available | — |
| 4. Furosemide 20mg and 40mg tablets remain available and can support increased demand. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.